Learn More
Medchemexpress LLC Roniciclib | 1223498-69-8 | 98.0% | 430.44 | 25 MG

Supplier: Medchemexpress LLC 25MGHY13914
Roniciclib is an orally bioavailable pan-cyclin dependent kinase (CDK) inhibitor. It has IC50s of 5-25 nM for CDK1, CDK2, CDK3, CDK4, CDK7, and CDK9.
- Inhibits the kinase activity of cell-cycle CDKs (CDK1/cyclin B, CDK2/cyclin E, and CDK4/cyclin D)
- Inhibits transcriptional CDKs (CDK9/cyclin T1 and CDK7/cyclin H/MAT1)
- Potently inhibits the proliferation of various human and murine tumor cell lines
- Strongly inhibits tumor growth in a dose-dependent manner
- Low blood clearance rates in mouse, rat, and dog
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.